NHS takes the next step in digital health
The shift in the medical space from traditional paper records to digital records has been difficult and filled with setbacks….
Read More…
Focus:
Uk
-
![]()
Low diagnosis of onychomycosis may inhibit adequate treatment
Dermatophytic onychomycosis (DO) is a form of chronic fungal infection of the nails caused by dermatophytes, a type of fungi…
Read More…
-
![UK NICE says more data required to approve Bayer’s Vitrakvi]()
UK NICE says more data required to approve Bayer’s Vitrakvi
The National Institute for Health and Care Excellence (NICE) in the UK has not recommended...
Read More...
-
![Oyster Point Pharma OC-01 nasal spray]()
How significant is a novel route of administration for dry eye syndrome?
Although treatments for dry eye syndrome (DES) have been well-established, lack of efficacy in their modes of action (MOAs) and…
Read More…
-
![Alexion ALS]()
Alexion bets on ALS with pivotal phase III study for its future blockbuster ultomiris
This quarter, Alexion Pharmaceuticals is set to launch a pivotal Phase III study of Ultomiris (ravulizumab) in amyotrophic lateral sclerosis…
Read More…
-
MiNA Therapeutics, AstraZeneca partner for metabolic diseases
UK-based MiNA Therapeutics has entered into a research collaboration agreement with AstraZeneca to assess small...
Read More...
-
![]()
Cancer Research UK to fund Bicycle’s immuno-oncology candidate
Cancer Research UK has agreed to fund exploratory development of Bicycle Therapeutics’ immuno-oncology candidate BT7401.
Read More...
-
MHRA grants licence update for Ipsen’s Dysport
UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence update for Ipsen’s...
Read More...
-
![]()
Malvern Panalytical
Malvern Panalytical has a wide range of characterisation technologies that can be used to accelerate...
Read More...
-
![]()
Endress+Hauser
Endress + Hauser provides process automation solutions for pharmaceutical companies, supporting projects ranging from pilot...
Read More...
